Gilead Sciences’ anti-HIV medication Truvada® contains tenofovir (TDF), a drug that is linked to severe side effects such as kidney failure, tooth decay, osteoporosis, and broken bones.

Truvada® is an anti-HIV and PrEP medication that is manufactured by Gilead Sciences and combines the medications Emtricitabine with Tenofovir Disoproxil Fumarate (TDF). It can be used to treat people who are infected with HIV. Truvada® for PReP is also used to prevent HIV infection in people who are at high risk of becoming infected.

Kidney Injuries Linked to Truvada®

• Chronic kidney disease
• Declining kidney function
• Acute kidney injury
• Acute renal failure
• Fanconi syndrome
• Kidney failure

Bone Injuries Linked to Truvada®

• Osteoporosis
• Decreased bone mineral density
• Osteopenia
• Bone fractures
• Dental problems
• Tooth decay
• Tooth loss

Lawsuits have been filed against Gilead Sciences by people who took Truvada® or other HIV medications and were subsequently diagnosed with broken bones, dental problems, osteoporosis, kidney failure, and other side effects.

Gilead is accused of intentionally selling Truvada® and other medications with TDF, an ingredient that has been linked to severe side effects. Gilead is also accused of failing to warn patients about the health risks.